CSIMarket
Liminal Biosciences Inc   (LMNL)
Other Ticker:  
 
 

Liminal Biosciences Inc 's Yearly Income from Continued Operations Growth 5 Years

 

Select the Comparisons : Select the Ratio:



LMNL Annual Income from Cont. Operations Growth

2022
2021
2020
2019

Y / Y Annual Income from Cont. Operations Change -94.91 % - - - -
Annual Income from Cont. Operations (in millions $) $0.48 $9.36 $-90.97 $-158.37 $0.00


Annual Income from Cont. Operations Growth Comment
Liminal Biosciences Inc experienced detoriation of Annual Income from Cont. Operations for the fiscal year ended 2022 by -94.91% to $ 0.48 millions, compare to $ 9.36 in Annual Income from Cont. Operations reported in the previous year. Liminal Biosciences Inc 's Income from Continued Operations decline slowed form -110.28 % contraction in the fiscal year 2021.

Liminal Biosciences Inc Annual Income Statement




You need to upgrade your Flash Player



Companies with similar 2022 Annual Income from Cont. Operations within Healthcare SectorY/Y Income from Continued Operations Growth %2022 Annual Income from Cont. Operations

Other Companies within Healthcare Sector and their 2022 Income from Continued Operations

Y/Y Annual Income from Cont. Operations Growth %

2022 Income from Continued Operations





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com